Athersys Company Profile

05:21 EDT 30th March 2015 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.

Location

3201 Carnegie Avenue
Cleveland
Ohio
44115-2634
United States of America

Contact

Phone: 216-431-9900
Fax: 216-361-9495
Email: jobs@athersys.com., ir@athersys.com


News Articles [35 Associated News Articles listed on BioPortfolio]

Athersys, Inc.: Athersys und Chugai schließen Lizenzvereinbarung und Zusammenarbeit zum Entwickeln der MultiStem(R)-Stammzellentherapie für ischämische Schlaganfälle in Japan ab

Partnerschaft im Bereich der regenerativen Medizin mit dem Schwerpunkt auf der Entwicklung einer neuen Stammzellentherapie CLEVELAND und TOKIO, 3. März 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nas...

Athersys (ATHX) - Chugai deal builds confidence

Edison Investment Research - Pharmaceutical & Healthcare - Athersys : The development of regenerative medicines in Japan presents a significant opportunity. Athersys has just taken a major step toward...

Athersys and Chugai announce pharma licensing deal for ischemic stroke

Athersys and Chugai Pharmaceutical have announced a partnership and pharma licensing agreement to exclusively develop and commercialize MultiStem cell therapy for ischemic stroke in Japan. Ischemic s...

Chugai-Athersys collaborate to develop MultiStem Cell Therapy

Biospectrum As part of the collaboration, Chugai will be responsible for the development and commercialization of Multi...

Athersys (ATHX) - Poised for pivotal stroke data

Edison Investment Research - Pharmaceutical & Healthcare - Athersys : Enrolment in the potentially pivotal Phase II study assessing MultiStem in ischaemic stroke patients is now complete. With a 90-da...

Athersys, Chugai partner on cell-therapy development, marketing

Athersys agreed to collaborate with Chugai Pharmaceutical to develop and market in Japan the former's MultiStem cell therapy, -More- 

Athersys and Chugai in Multistem cell therapy pact

Athersys and Chugai Pharmaceutical have announced a partnership and license agreement to exclusively develop and commercialize MultiStem cell therapy for ischemic stroke in Japan. Ischemic stroke repr...

Chugai Signals Cell Therapy Interest Via Athersys Deal

The U.S. venture Athersys has entered into a cell therapy alliance with Chugai that will enable it to take advantage of the newly supportive regulatory environment in Japan for regenerative medicines ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record